You are here: Home » News-CM » Companies » Results
Business Standard

Medicamen Biotech standalone net profit rises 1.86% in the June 2019 quarter

Capital Market 

Sales decline 4.98% to Rs 31.13 crore

Net profit of Medicamen Biotech rose 1.86% to Rs 3.28 crore in the quarter ended June 2019 as against Rs 3.22 crore during the previous quarter ended June 2018. Sales declined 4.98% to Rs 31.13 crore in the quarter ended June 2019 as against Rs 32.76 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales31.1332.76 -5 OPM %16.0912.88 -PBDT4.895.02 -3 PBT4.324.54 -5 NP3.283.22 2

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, August 16 2019. 10:06 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU